ICICI Lombard General Insurance Company Ltd
ICICI Lombard General Insurance Co. Ltd is one of the leading and established private sector general insurance companies in India. It offers a well-diversified range of products and risk management solutions through multiple distribution channels.[1]
It was established in 2001 as a JV between ICICI Bank and Fairfax Financial Holdings Ltd. ICICI held 64% stake and the rest was held by JV partner. Fairfax Financial exited in 2019 by selling its remaining 5% stake in the company for ~2,600 crores.[2]
- Market Cap ₹ 89,395 Cr.
- Current Price ₹ 1,806
- High / Low ₹ 2,302 / 1,354
- Stock P/E 40.2
- Book Value ₹ 275
- Dividend Yield 0.33 %
- ROCE 22.5 %
- ROE 17.0 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 31.4%
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Insurance Industry: Finance & Investments
Part of Nifty Next 50 BSE Diversified Financials Revenue Growth Index (I BSE 100 LargeCap TMC Index Nifty LargeMidcap 250 Nifty100 ESG
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4,012 | 4,352 | 4,234 | 6,033 | 7,520 | 6,912 | 11,163 | 11,517 | 12,183 | 16,026 | 17,876 | 20,487 | 22,315 | |
4,191 | 4,578 | 4,456 | 5,269 | 6,601 | 7,174 | 9,494 | 9,745 | 10,594 | 15,010 | 16,612 | 17,910 | 19,378 | |
Operating Profit | -178 | -225 | -221 | 764 | 919 | -262 | 1,669 | 1,772 | 1,589 | 1,016 | 1,264 | 2,577 | 2,937 |
OPM % | -4% | -5% | -5% | 13% | 12% | -4% | 15% | 15% | 13% | 6% | 7% | 13% | 13% |
586 | 817 | 992 | 0 | -2 | 1,569 | -2 | 15 | 495 | 809 | 991 | 112 | 27 | |
Interest | 8 | 9 | 12 | 0 | 0 | 59 | 70 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation | 49 | 50 | 54 | 57 | 7 | 51 | 0 | 90 | 130 | 141 | 142 | 134 | 0 |
Profit before tax | 351 | 533 | 705 | 708 | 910 | 1,196 | 1,598 | 1,697 | 1,954 | 1,684 | 2,113 | 2,555 | 2,965 |
Tax % | -0% | 3% | 17% | 28% | 23% | 28% | 34% | 30% | 25% | 24% | 18% | 25% | |
353 | 520 | 585 | 507 | 702 | 862 | 1,049 | 1,194 | 1,473 | 1,271 | 1,729 | 1,919 | 2,225 | |
EPS in Rs | 8.07 | 11.69 | 13.11 | 11.34 | 15.56 | 18.98 | 23.10 | 26.27 | 32.40 | 25.89 | 35.21 | 38.94 | 45.10 |
Dividend Payout % | 0% | 0% | 15% | 26% | 22% | 17% | 26% | 13% | 25% | 35% | 31% | 28% |
Compounded Sales Growth | |
---|---|
10 Years: | 17% |
5 Years: | 13% |
3 Years: | 19% |
TTM: | 17% |
Compounded Profit Growth | |
---|---|
10 Years: | 14% |
5 Years: | 13% |
3 Years: | 9% |
TTM: | 27% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 6% |
3 Years: | 8% |
1 Year: | 27% |
Return on Equity | |
---|---|
10 Years: | 18% |
5 Years: | 18% |
3 Years: | 17% |
Last Year: | 17% |
Balance Sheet
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 437 | 445 | 447 | 448 | 451 | 454 | 454 | 454 | 455 | 491 | 491 | 493 | 495 |
Reserves | 1,433 | 1,949 | 2,439 | 2,789 | 3,450 | 4,087 | 4,946 | 5,680 | 7,144 | 8,702 | 9,953 | 11,712 | 13,127 |
0 | 0 | 0 | 0 | 485 | 485 | 485 | 485 | 485 | 255 | 35 | 35 | 0 | |
10,767 | 12,350 | 11,760 | 12,440 | 18,965 | 24,723 | 27,517 | 30,423 | 31,214 | 41,401 | 44,607 | 51,068 | 54,392 | |
Total Liabilities | 12,637 | 14,744 | 14,646 | 15,676 | 23,351 | 29,750 | 33,403 | 37,042 | 39,298 | 50,848 | 55,086 | 63,308 | 68,014 |
390 | 373 | 381 | 510 | 516 | 368 | 1,965 | 664 | 717 | 941 | 883 | 930 | 760 | |
CWIP | 10 | 17 | 9 | 10 | 11 | 38 | 17 | 12 | 14 | 11 | 25 | 94 | 0 |
Investments | 7,800 | 9,290 | 10,200 | 11,426 | 14,806 | 18,193 | 20,714 | 26,327 | 30,788 | 38,412 | 42,836 | 48,584 | 51,557 |
4,436 | 5,064 | 4,056 | 3,730 | 8,018 | 11,151 | 10,707 | 10,039 | 7,779 | 11,485 | 11,342 | 13,700 | 15,697 | |
Total Assets | 12,637 | 14,744 | 14,646 | 15,676 | 23,351 | 29,750 | 33,403 | 37,042 | 39,298 | 50,848 | 55,086 | 63,308 | 68,014 |
Cash Flows
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
984 | 595 | -98 | 511 | 1,628 | 2,390 | 2,976 | 3,433 | 1,774 | 809 | 2,290 | 2,407 | |
-962 | -706 | 171 | -310 | -1,990 | -1,896 | -2,856 | -3,382 | -1,367 | 135 | -1,685 | -1,921 | |
102 | 4 | -93 | -148 | 361 | -96 | -310 | -420 | -212 | -879 | -695 | -355 | |
Net Cash Flow | 124 | -108 | -20 | 53 | -1 | 398 | -190 | -369 | 195 | 65 | -90 | 131 |
Ratios
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 0 | 0 | 0 | 0 | 0 | 0 | 292 | 0 | 0 | 0 | 0 | 0 |
Inventory Days | ||||||||||||
Days Payable | ||||||||||||
Cash Conversion Cycle | 0 | 0 | 0 | 0 | 0 | 0 | 292 | 0 | 0 | 0 | 0 | 0 |
Working Capital Days | -529 | -519 | -576 | -532 | -521 | -720 | -564 | -670 | -704 | -690 | -685 | -664 |
ROCE % | 18% | 26% | 27% | 23% | 24% | 17% | 31% | 27% | 27% | 19% | 21% | 23% |
Documents
Announcements
- Disclosure Under Regulation 30 Read With Schedule III And Regulation 46(2) Of The SEBI (LODR) Regulations, 2015 2m
-
Disclosure Under Regulation 30 Read With Schedule III And Regulation 46(2) Of The SEBI (LODR) Regulations, 2015
1d - Schedule of analyst/investor meetings on November 19, 2024.
-
Disclosure Under Regulation 30 Read With Schedule III And Regulation 46(2) Of The SEBI (LODR) Regulations, 2015
2d - Disclosure of analyst and investor meetings held on November 18, 2024.
-
Disclosure Under Regulation 30 Read With Schedule III And Regulation 46(2) Of The SEBI (LODR) Regulations, 2015
15 Nov - Disclosure of analyst/investor meetings held on November 14, 2024.
-
Disclosure Under Regulation 30 Read With Schedule III And Regulation 46(2) Of The SEBI (LODR) Regulations, 2015
14 Nov - Disclosure of analyst and investor meetings held.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Concalls
-
Oct 2024Transcript PPT
-
Jul 2024Transcript PPT
-
Apr 2024Transcript PPT
-
Jan 2024Transcript PPT
-
Oct 2023Transcript PPT
-
Jul 2023Transcript PPT
-
Apr 2023TranscriptPPT
-
Apr 2023Transcript PPT
-
Apr 2023TranscriptPPT
-
Jan 2023Transcript PPT
-
Nov 2022TranscriptNotesPPT
-
Oct 2022Transcript PPT
-
Jul 2022TranscriptPPT
-
Jul 2022TranscriptPPT
-
Apr 2022Transcript PPT
-
Jan 2022Transcript PPT
-
Oct 2021TranscriptNotesPPT
-
Sep 2021TranscriptNotesPPT
-
Jul 2021TranscriptNotesPPT
-
May 2021TranscriptNotesPPT
-
Apr 2021TranscriptNotesPPT
-
Jan 2021TranscriptNotesPPT
-
Dec 2020TranscriptNotesPPT
-
Dec 2020TranscriptNotesPPT
-
Nov 2020TranscriptNotesPPT
-
Oct 2020TranscriptNotesPPT
-
Sep 2020TranscriptNotesPPT
-
Jul 2020TranscriptNotesPPT
-
May 2020TranscriptNotesPPT
-
Jan 2020TranscriptNotesPPT
-
Oct 2019TranscriptNotesPPT
-
Jul 2019TranscriptNotesPPT
-
Apr 2019TranscriptNotesPPT
-
Jan 2019TranscriptNotesPPT
-
Oct 2018TranscriptNotesPPT
-
Jan 2018TranscriptPPT
-
Nov 2017TranscriptNotesPPT
-
Nov 2017Transcript PPT
Ratios (FY21)
Incurred Claims Ratio - 75%
Commission Ratio - 5%
Combined Ratio - 109%
Solvency Ratio - 246%
Net Retention Ratio - 73% [1]